Cyclobutanes in Small-Molecule Drug Candidates

被引:116
|
作者
van der Kolk, Marnix R. [1 ]
Janssen, Mathilde A. C. H. [1 ]
Rutjes, Floris P. J. T. [1 ]
Blanco-Ania, Daniel [1 ]
机构
[1] Radboud Univ Nijmegen, Inst Mol & Mat, Heyendaalseweg 135, NL-6526 AJ Nijmegen, Netherlands
基金
荷兰研究理事会;
关键词
Cyclobutanes; strained carbocycles; conformational restriction; pharmacophores; isosteres; HISTAMINE H-3 RECEPTOR; GLYCOGEN-SYNTHASE KINASE-3; APOLIPOPROTEIN-E; GLUCOKINASE ACTIVATORS; BIOLOGICAL EVALUATION; HISTONE MODIFICATIONS; SELECTIVE INHIBITORS; INDAZOLE DERIVATIVES; STRUCTURAL BASIS; POTENTIAL ROLE;
D O I
10.1002/cmdc.202200020
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cyclobutanes are increasingly used in medicinal chemistry in the search for relevant biological properties. Important characteristics of the cyclobutane ring include its unique puckered structure, longer C-C bond lengths, increased C-C pi-character and relative chemical inertness for a highly strained carbocycle. This review will focus on contributions of cyclobutane rings in drug candidates to arrive at favorable properties. Cyclobutanes have been employed for improving multiple factors such as preventing cis/trans-isomerization by replacing alkenes, replacing larger cyclic systems, increasing metabolic stability, directing key pharmacophore groups, inducing conformational restriction, reducing planarity, as aryl isostere and filling hydrophobic pockets.
引用
收藏
页数:22
相关论文
共 50 条
  • [41] Shape shifting leads to small-molecule allosteric drug discovery
    Lawrence, Sarah H.
    Ramirez, Ursula D.
    Tang, Lei
    Fazliyez, Farit
    Kundrat, Lenka
    Markham, George D.
    Jaffe, Eileen K.
    CHEMISTRY & BIOLOGY, 2008, 15 (06): : 586 - 596
  • [43] First small-molecule drug targeting RNA gains momentum
    Cormac Sheridan
    Nature Biotechnology, 2021, 39 : 6 - 8
  • [44] Targeting transthyretin in Alzheimer's disease: Drug discovery of small-molecule chaperones as disease-modifying drug candidates for Alzheimer's disease
    Cotrina, Ellen Y.
    Santos, Luis Miguel
    Rivas, Josep
    Blasi, Daniel
    Leite, Jose Pedro
    Liz, Marcia A.
    Antonia Busquets, Maria
    Planas, Antoni
    Prohens, Rafel
    Gimeno, Ana
    Jimenez-Barbero, Jesus
    Gales, Luis
    Llop, Jordi
    Quintana, Jordi
    Cardoso, Isabel
    Arsequell, Gemma
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 226
  • [45] Small-molecule catalysis
    Andrew Mitchinson
    Joshua Finkelstein
    Nature, 2008, 455 : 303 - 303
  • [46] Small-molecule mimetics
    Murcko, M
    DRUG DISCOVERY TODAY, 1996, 1 (10) : 408 - 410
  • [47] Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands
    Cummings, Maxwell D.
    Sekharan, Sivakumar
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (15) : 6843 - 6853
  • [48] RITA - a small-molecule anticancer drug that targets p53
    Doggrell, SA
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (06) : 739 - 742
  • [49] Impact of target interactions on small-molecule drug disposition: an overlooked area
    van Waterschoot, Robert A. B.
    Parrott, Neil J.
    Olivares-Morales, Andres
    Lave, Thierry
    Rowland, Malcolm
    Smith, Dennis A.
    NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (04) : 299 - +
  • [50] Solvated interaction energy: from small-molecule to antibody drug design
    Purisima, Enrico O. O.
    Corbeil, Christopher R. R.
    Gaudreault, Francis
    Wei, Wanlei
    Deprez, Christophe
    Sulea, Traian
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10